Microsoft (MSFT) delivered better second-quarter results than many on Wall Street anticipated, initially sending shares soaring in afterhours trading. But the stock retreated after management announced softer-than-expected guidance for the technology giant’s third quarter — underscoring our decision to remain sidelined buyers for now. Revenue for the three months ended Dec. 31 came in at $52.75 billion, slightly missing analysts’ forecasts of $52.94 billion, according to estimates from Refinitiv, even as revenue growth from the cloud computing unit, Azure, slightly outperformed expectations. Adjusted earnings-per-share of $2.32 a share beat analysts’ estimates by 3 cents. Bottom line Microsoft was able to pull off a quarter that was not as poor as feared, boosting shares 3% to 4% after the market closed. It was a welcomed, if brief, relief …
Latest Business News
Regenerative Agriculture: Restoring Ecosystems While Increasing Productivity (6/12/2026) - Full session recording featuring Monica McBride of Bayer and Tom… Read more...
Can AI Improve Global Health Without Trust, Equity, and Accountability? (6/10/2026) - Full session recording featuring David Lazerson of Briya and Jonathan… Read more...
The New Architecture of Value (6/8/2026) - Full session recording featuring Amy Terpeluk and Gil Bashe of… Read more...
The Emergence of Decision Trust Infrastructure: Why Defensible AI Is Now a Board-Level Conversation (6/5/2026) - 1BusinessWorld • 1ArtificialIntelligence The Emergence of Decision Trust Infrastructure Chiru… Read more...
Regulating Innovation: How Policy is Reshaping the Future of Health (6/5/2026) - Full session recording featuring David Farber of King & Spalding… Read more...
From Innovation to Impact: Rewiring Health Delivery for the AI Era (6/4/2026) - Full session recording featuring Arturo LoAIza-Bonilla joining host Fern Lazar… Read more...
AI and Cloud Security in the Age of Enterprise Autonomy (6/3/2026) - AI and Cloud Security in the Age of Enterprise AutonomyAI… Read more...
What It Takes to Bring Clinical AI into Real Practice (5/30/2026) - Full session recording featuring Junmyung Kwon, Founder and CEO of… Read more...